triazoles has been researched along with deoxyglucose in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 12 (70.59) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Barrachina, D; Beltrán, B; Calatayud, S; Martínez-Cuesta, A; Ramírez, C | 1 |
| Anderson, KE; Daniele, N; Foukas, LC; Jensen, J; Ktori, C; Shepherd, PR | 1 |
| Dahl, RS; Finney, NS | 1 |
| Forster, WA; Riederer, M; Zabkiewicz, JA | 1 |
| Mukherjee, D; Taneja, SC; Yousuf, SK | 1 |
| Golovan, AV; Gudz, GP; Kanishchev, OS; Nesterova, NV; Shermolovich, YG; Zagorodnya, SD | 1 |
| Kishimoto, M; Noda, M | 1 |
| Ando, K; Irako, T; Nishimura, R; Sakamoto, M; Tsujino, D; Utsunomiya, K | 1 |
| Araki, E; Furukawa, N; Goto, R; Ichimori, S; Iwashita, S; Kawashima, J; Kondo, T; Maeda, T; Matsumura, T; Matsuo, T; Matsuo, Y; Motoshima, H; Nishida, K; Sekigami, T; Shimoda, S | 1 |
| Kawata, T; Matsubara, F; Nagai, Y; Nakamura, Y; Ohshige, T; Ohta, A; Sakai, K; Tanaka, Y; Tenjin, A; Terashima, Y; Tsukiyama, S | 1 |
| Forster, WA; Kimberley, MO | 1 |
| Gatti, FM; Shamim, A; Souza, FB; Stefani, HA; Trossini, GH | 1 |
| Chen, C; Chen, W; Guo, L; Ju, R; Li, J; Ye, C; Yu, X; Zhang, D; Zhu, L | 1 |
| Baleja, JD; Degterev, A; Dutta, I; Jhaveri, A; Pattni, BS; Torchilin, V | 1 |
| Bednarek, P; Kwaaitaal, M; Panstruga, R; Schaffrath, U; Strugala, R; Wu, H | 1 |
| Chen, C; Fei, K; Guo, L; Ju, R; Li, J; Li, S; Ye, C; Zhang, D; Zhu, L | 1 |
| Chen, XS; Cheng, Y; Li, LY; Tian, M; Wang, XL; Wu, HZ; Xiao, SS; Zeng, D; Zhang, Y | 1 |
3 trial(s) available for triazoles and deoxyglucose
| Article | Year |
|---|---|
Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): crossover pilot study (J-VICTORIA study).
Topics: Adamantane; Adult; Aged; Biomarkers; Blood Glucose; C-Peptide; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Schedule; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Japan; Male; Middle Aged; Monitoring, Ambulatory; Natriuretic Peptide, Brain; Nitriles; Pilot Projects; Plasminogen Activator Inhibitor 1; Postprandial Period; Predictive Value of Tests; Pyrazines; Pyrrolidines; Serum Albumin; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles; Vildagliptin | 2012 |
Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy.
Topics: Aged; Asian People; Blood Glucose; Blood Glucose Self-Monitoring; Body Mass Index; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Triazoles | 2013 |
Comparison of the hypoglycemic effect of sitagliptin versus the combination of mitiglinide and voglibose in drug-naïve Japanese patients with type 2 diabetes.
Topics: Aged; Asian People; Blood Glucose; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Inositol; Insulin; Isoindoles; Male; Middle Aged; Pyrazines; Serum Albumin; Sitagliptin Phosphate; Triazoles | 2013 |
14 other study(ies) available for triazoles and deoxyglucose
| Article | Year |
|---|---|
Effects of endotoxin on neurally-mediated gastric acid secretion in the rat.
Topics: Animals; Azepines; Blood Pressure; Deoxyglucose; Dose-Response Relationship, Drug; Endotoxins; Escherichia coli; Female; Gastric Acid; Male; Naloxone; Narcotic Antagonists; Opioid Peptides; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Opioid; Stomach; Triazoles | 1997 |
Direct effects of caffeine and theophylline on p110 delta and other phosphoinositide 3-kinases. Differential effects on lipid kinase and protein kinase activities.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Biological Transport; Caffeine; CHO Cells; Cricetinae; Deoxyglucose; Dimerization; Flavins; Glucose; Kinetics; Monosaccharide Transport Proteins; Phosphatidylinositol 3-Kinases; Phosphorylation; Quinazolines; Recombinant Fusion Proteins; Theophylline; Transfection; Triazoles | 2002 |
A surprising dipolar cycloaddition provides ready access to aminoglycosides.
Topics: Aminoglycosides; Cyclization; Deoxyglucose; Triazoles | 2004 |
Mechanisms of cuticular uptake of xenobiotics into living plants: 1. Influence of xenobiotic dose on the uptake of three model compounds applied in the absence and presence of surfactants into Chenopodium album, Hedera helix and Stephanotis floribunda lea
Topics: 2,4-Dichlorophenoxyacetic Acid; Adsorption; Apocynaceae; Chenopodium album; Deoxyglucose; Dose-Response Relationship, Drug; Epoxy Compounds; Hedera; Herbicides; Mathematics; Plant Leaves; Surface-Active Agents; Triazoles; Xenobiotics | 2004 |
Multicomponent cascade transformation of D-glucal to furan-appended triazole glycoconjugates.
Topics: Catalysis; Copper; Deoxyglucose; Furans; Glycoconjugates; Mesylates; Molecular Structure; Triazoles | 2010 |
Synthesis and biological activity of the nucleoside analogs based on polyfluoroalkyl-substituted 1,2,3-triazoles.
Topics: Antiviral Agents; Cell Line, Tumor; Cytomegalovirus; Deoxyglucose; Herpesvirus 4, Human; Humans; Nucleosides; Structure-Activity Relationship; Tosyl Compounds; Triazoles | 2011 |
A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers.
Topics: 1-Deoxynojirimycin; Aged; Biomarkers; Blood Glucose; Case-Control Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Middle Aged; Monitoring, Physiologic; Pilot Projects; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles | 2011 |
The contribution of spray formulation component variables to foliar uptake of agrichemicals.
Topics: 2,4-Dichlorophenoxyacetic Acid; Chenopodium album; Deoxyglucose; Epoxy Compounds; Fungicides, Industrial; Herbicides; Hydrophobic and Hydrophilic Interactions; Plant Leaves; Surface-Active Agents; Triazoles | 2015 |
Synthesis of C-glycosyl-bis-1,2,3-triazole derivatives from 3,4,6-tri-O-acetyl-D-glucal.
Topics: Catalysis; Chemistry Techniques, Synthetic; Click Chemistry; Copper; Deoxyglucose; Glycosylation; Iodides; Triazoles | 2015 |
Carboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anti-cancer effect with glycolysis inhibition.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Drug Synergism; Glucose; Glycolysis; Humans; Mice; Mice, Inbred C57BL; Oxidative Phosphorylation; Oxygen Consumption; Triazoles | 2016 |
Targeting energy metabolism of cancer cells: Combined administration of NCL-240 and 2-DG.
Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Survival; Chlorophenols; Deoxyglucose; Drug Interactions; Energy Metabolism; Humans; Liposomes; Neoplasms; Triazoles | 2017 |
Chemical suppressors of
Topics: Agriculture; Agrochemicals; Brefeldin A; DDT; Deoxyglucose; Disease Resistance; Hordeum; Plant Proteins; Ribonucleosides; Spermidine; Triazoles | 2017 |
Metabolic Mechanisms and a Rational Combinational Application of Carboxyamidotriazole in Fighting Pancreatic Cancer Progression after Chemotherapy.
Topics: Animals; Antineoplastic Agents; Aspartic Acid; Cell Line, Tumor; Cell Proliferation; Cell Respiration; Deoxyglucose; Disease Progression; Drug Interactions; Female; Glycolysis; Humans; Intracellular Space; Mice; Mice, Inbred BALB C; Mitochondria; Pancreatic Neoplasms; Triazoles; Xenograft Model Antitumor Assays | 2018 |
Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis.
Topics: Animals; Antineoplastic Agents; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Cell Line, Tumor; Cell Proliferation; Cisplatin; Deoxyglucose; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Glycolysis; HEK293 Cells; Humans; Mice, Nude; Ovarian Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Triazoles; Xenograft Model Antitumor Assays | 2021 |